CETUXIMAB IN COMBINATION WITH CISPLATIN PLUS DOCETAXEL TO EVALUATE THE ACTIVITY AND SAFETY IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC GASTRIC AND GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA: PHASE I...

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-003838-15

CETUXIMAB IN COMBINATION WITH CISPLATIN PLUS DOCETAXEL TO EVALUATE THE ACTIVITY AND SAFETY IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC GASTRIC AND GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA: PHASE II DOCETUX STUDY

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

ユ To investigate the efficacy and safety of Cetuximab in combination with Docetaxel plus Cisplatin in patients with locally advanced or metastatic gastric and gastroesophageal junction adenocarcinoma , not previously treated with chemotherapy.


Critère d'inclusion

  • Advanced or metastatic gastric and gastroesophageal junction adenocarcinoma

Liens